Form 4 for IDXX Idexx Laboratories
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-13 · accession 0000874716-25-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-18 | 2025-02-14 | IDXX | FENNELL GEORGE | EVP | M - OptEx | $0.00 | +304 | 8,227 | +4% | $0 |
| D | 2025-02-18 | 2025-02-14 | IDXX | FENNELL GEORGE | EVP | F - Tax | $444.53 | -133 | 8,347 | -2% | -$59.1K |
| DM | 2025-02-18 | 2025-02-14 | IDXX | FENNELL GEORGE | EVP | M - OptEx | $0.00 | -304 | 417 | -42% | $0 |
| DM | 2025-02-18 | 2025-02-13 | IDXX | FENNELL GEORGE | EVP | A - Grant | $0.00 | +4,448 | 3,415 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-14 | M | A | 140 | $0.00 | 8,480 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-14 | M | A | 57 | $0.00 | 8,340 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-14 | M | A | 56 | $0.00 | 8,283 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-14 | M | A | 51 | $0.00 | 8,227 | D | — | — | |
| 5 | Common | Common Stock | 2025-02-14 | F | D | 133 | $444.53 | 8,347 | D | — | — | |
| 6 | Derivative | Restricted Stock Unit | 2025-02-14 | M | D | 57 | $0.00 | 112 | D | — · — to — | 57 Common Stock | (F6) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2024. |
| 7 | Derivative | Restricted Stock Unit | 2025-02-14 | M | D | 56 | $0.00 | 55 | D | — · — to — | 56 Common Stock | (F5) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2023. |
| 8 | Derivative | Restricted Stock Unit | 2025-02-14 | M | D | 51 | $0.00 | 0 | D | — · — to — | 51 Common Stock | (F4) Each RSU represents a contingent right to receive one share of Issuer. common stock and vested in four annual installments, beginning on February 14, 2022. |
| 9 | Derivative | Restricted Stock Unit | 2025-02-13 | A | A | 816 | $0.00 | 816 | D | — · — to — | 816 Common Stock | (F3) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026. |
| 10 | Derivative | Incentive Stock Option (right-to-buy) | 2025-02-13 | A | A | 217 | $0.00 | 217 | D | $459.76 · — to 2035-02-12 | 217 Common Stock | (F2) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029. |
| 11 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2025-02-13 | A | A | 3,415 | $0.00 | 3,415 | D | $459.76 · — to 2035-02-12 | 3,415 Common Stock | (F1) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026. |
| 12 | Derivative | Restricted Stock Unit | 2025-02-14 | M | D | 140 | $0.00 | 417 | D | — · — to — | 140 Common Stock | (F7) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2025. |